This product is a recombinant mouse antibody that recognizes FCGR2. The antibody was purified by affinity chromatography. It can be used in Block, Stim, WB, FC, IF.
Figure 1 Cross-blocking of anti-FcγRIIB mAb.
BALB/c splenocytes were incubated with unlabelled mAb before labelling with FITC-mAb and PE-CD19 (to identify B cells) and analysed by flow cytometry. OKT3 was used as an irrelevant control (Irr). AT130-2 and AT130-5 binding could only be blocked by themselves and each other, whereas the binding of AT128 and 2.4G2 could be blocked by all of the anti-FcγRIIB mAb.
Williams, E. L., Tutt, A. L., French, R. R., Chan, H. C., Lau, B., Penfold, C. A., ... & Cragg, M. S. (2012). Development and characterisation of monoclonal antibodies specific for the murine inhibitory F cγ RIIB (CD 32 B). European journal of immunology, 42(8), 2109-2120.
Figure 2 Cross-blocking of anti-FcγRIIB mAb.
BALB/c splenocytes were incubated with unlabelled mAb IgG (top panel) or F(ab')2 (bottom panel) before the addition of rabbit-anti-ova/ova-FITC ICs) and analysed by flow cytometry. Data in (A) and (B) represent an example of three experiments, where single samples were run per condition.
Williams, E. L., Tutt, A. L., French, R. R., Chan, H. C., Lau, B., Penfold, C. A., ... & Cragg, M. S. (2012). Development and characterisation of monoclonal antibodies specific for the murine inhibitory F cγ RIIB (CD 32 B). European journal of immunology, 42(8), 2109-2120.
Figure 3 Binding profiles of anti-FcγRIIB mAb.
BALB/c peripheral blood lymphocytes from WT, FcγRIIB−/− or FcγRIII−/− mice labelled with FITC-mAb and analysed by flow cytometry.
Williams, E. L., Tutt, A. L., French, R. R., Chan, H. C., Lau, B., Penfold, C. A., ... & Cragg, M. S. (2012). Development and characterisation of monoclonal antibodies specific for the murine inhibitory F cγ RIIB (CD 32 B). European journal of immunology, 42(8), 2109-2120.
Figure 4 Activation of FcγRIIB and SHIP-1 by anti-FcγRIIB mAb.
πBCL1 cells at varying concentrations (2, 0.4, and 0.1 × 106 cells/mL) were incubated with anti-FcγRIIB mAb and anti-idiotype mAb at 37°C for 5 min and then lysed and analysed for pFcγRIIB. The relative cell densities achieved at these cell concentrations were demonstrated by bright field microscopy, ×10 magnification (scale bar is equal to 10 μm).
Williams, E. L., Tutt, A. L., French, R. R., Chan, H. C., Lau, B., Penfold, C. A., ... & Cragg, M. S. (2012). Development and characterisation of monoclonal antibodies specific for the murine inhibitory F cγ RIIB (CD 32 B). European journal of immunology, 42(8), 2109-2120.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for FAMAB-1624CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.